Albuminuria by diabetes mellitus: Marker and motor of diabetic nephropathy and vascular complications

被引:0
|
作者
Hunger-Dathe W. [1 ,2 ]
Wolf G. [1 ]
机构
[1] Klinik für Innere Medizin III, Klinikum, Friedrich-Schiller-Universität, Jena
[2] Klinik für Innere Medizin III, Klinikum, Friedrich-Schiller-Universität
来源
Der Diabetologe | 2006年 / 2卷 / 5期
关键词
Cardiovascular morbidity; Diabetic nephropathy; Microalbuminuria; Myocardial infarct; Stroke;
D O I
10.1007/s11428-006-0069-z
中图分类号
学科分类号
摘要
Diabetic nephropathy requires intensive treatment as it is the main reason for the morbidity and mortality resulting from diabetes mellitus. Patients with diabetic nephropathy have a significantly higher mortality rate due to cardiovascular events such as myocardial infarct or stroke. Microalbuminuria is the earliest clinical sign of diabetic renal disease and is also a marker for increased cardiovascular morbidity and mortality. Thus, its early detection allows not only for effective secondary prevention of the progression of diabetic nephropathy, but is also an indication for the implementation of an individually-tailored cardiovascular risk reduction management program. People with diabetes mellitus are high risk patients who need intensive monitoring and intensive supportive therapy. © Springer Medizin Verlag 2006.
引用
收藏
页码:400 / 409
页数:9
相关论文
共 50 条
  • [31] Risk factors for diabetic nephropathy complications in community patients with type 2 diabetes mellitus in Shanghai: Logistic regression and classification tree model analysis
    Lou, Jieqiong
    Jing, Limei
    Yang, Hui
    Qin, Fei
    Long, Wen
    Shi, Rong
    INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT, 2019, 34 (03) : 1013 - 1024
  • [32] Serum VEGF as a predictive marker of glycemic control and diabetic nephropathy in Chinese older adults with type 2 diabetes mellitus
    Jiang, Yanyan
    Li, Jianhua
    Zhang, Juan
    Chen, Sufang
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [33] INCREASED RENAL RESISTIVE INDEX AS A MARKER OF EARLY STAGE OF DIABETIC NEPHROPATHY IN NORMOALBUMINURIC CHILDREN WITH TYPE 1 DIABETES MELLITUS
    Trutin, Ivana
    Stipancic, Gordana
    Sapina, Matej
    Oletic, Lea
    Laganovic, Mario
    ACTA CLINICA CROATICA, 2024, 63 (01) : 36 - 44
  • [34] Serum cathelicidin as a marker for diabetic nephropathy in patients with type 1 diabetes
    El-Ashmawy, Hazem M.
    Ahmed, Azza M.
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34 (08)
  • [35] Dyslipidemia And Nephropathy In Diabetes Mellitus: A Review
    Aggarwal, Juhi
    Chaudhari, Uma Kant
    Batra, Jyoti
    Sharma, Sandeep Ku-Mar
    CARDIOMETRY, 2022, (25): : 1192 - 1196
  • [36] Diabetic nephropathy and myocardial lesions in children with type 1 diabetes mellitus
    Kazakova, L. V.
    Azova, E. A.
    Lukushkina, E. F.
    Strongin, L. G.
    DIABETES MELLITUS, 2009, 12 (03): : 43 - 48
  • [37] Nodular glomerulosclerosis mimicking diabetic nephropathy without overt diabetes mellitus
    Chang, CS
    Yang, AH
    Chang, CH
    CLINICAL NEPHROLOGY, 2005, 64 (04) : 300 - 304
  • [38] Associations of serum Magnesium levels with diabetes mellitus and diabetic complications
    Arpaci, D.
    Tocoglu, A. G.
    Ergenc, H.
    Korkmaz, S.
    Ucar, A.
    Tamer, A.
    HIPPOKRATIA, 2015, 19 (02) : 153 - 157
  • [39] Monoclonal Antibody Pharmacokinetics in Type 2 Diabetes Mellitus and Diabetic Nephropathy
    Chadha G.S.
    Morris M.E.
    Current Pharmacology Reports, 2016, 2 (2) : 45 - 56
  • [40] Diabetic nephropathy in a nonobese mouse model of Type 2 diabetes mellitus
    Mallipattu, Sandeep K.
    Gallagher, Emily J.
    LeRoith, Derek
    Liu, Ruijie
    Mehrotra, Anita
    Horne, Sylvia J.
    Chuang, Peter Y.
    Yang, Vincent W.
    He, John C.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2014, 306 (09) : F1008 - F1017